Conference
A Predictive Model for Determining the Efficacy of Multiple Doses of QGE031 (Ligelizumab) Versus Omalizumab and Placebo in Inhibiting the Allergen-Induced Early Asthmatic Response
Authors
Gauvreau GM; Boulet L-P; Leigh R; Cockcroft DW; Davis BE; Mayers I; FitzGerald JM; Dahlen B; Watson RM; Milot J
Volume
191
Pagination
pp. a2488-a2488
Publication Date
January 1, 2015
DOI
10.1164/ajrccm-conference.2015.191.1_meetingabstracts.a2488
Conference proceedings
American Journal of Respiratory and Critical Care Medicine
Issue
Supplement_1
ISSN
1073-449X
